{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:24:24Z","timestamp":1787311464635,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.breast.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T16:30:19Z","timestamp":1468686619000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"D.","family":"Andreis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Aguggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gussago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ungari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Roviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Polom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Generali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.breast.2016.07.003_bib1","first-page":"1195","article-title":"Impact of sentinel node tumor burden on outcome of invasive breast cancer patients","volume":"40","author":"Meattini","year":"2014","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2016.07.003_bib2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0039-6109(05)70061-X","article-title":"Management of the axilla in primary breast cancer","volume":"79","author":"Jatoi","year":"1999","journal-title":"Surg Clin North Am"},{"issue":"9069","key":"10.1016\/j.breast.2016.07.003_bib3","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.breast.2016.07.003_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer\u2013a multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N.\u00a0Engl J Med"},{"issue":"30","key":"10.1016\/j.breast.2016.07.003_bib5","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"13","key":"10.1016\/j.breast.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1200\/JCO.2000.18.13.2560","article-title":"Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used","volume":"18","author":"McMasters","year":"2000","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jamasurg.2013.4350","article-title":"Surgeon specialization and use of sentinel lymph node biopsy for breast cancer","volume":"149","author":"Yen","year":"2014","journal-title":"JAMA Surg"},{"issue":"1","key":"10.1016\/j.breast.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0093-7754(01)90042-9","article-title":"Adjuvant and neoadjuvant treatment of breast cancer","volume":"28","author":"Gianni","year":"2001","journal-title":"Seminars Oncol"},{"issue":"7","key":"10.1016\/j.breast.2016.07.003_bib10","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J\u00a0Clin Oncol official J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N.\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.breast.2016.07.003_bib12","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1200\/JCO.2000.18.20.3480","article-title":"Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer","volume":"18","author":"Breslin","year":"2000","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2016.07.003_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cncr.21568","article-title":"Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis","volume":"106","author":"Kim","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.breast.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/cncr.10539","article-title":"Consensus Conference C. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania","volume":"94","author":"Schwartz","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"15","key":"10.1016\/j.breast.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1677\/erc.1.00945","article-title":"Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial","volume":"12","author":"Bottini","year":"2005","journal-title":"Endocrine Related Cancer"},{"issue":"3A","key":"10.1016\/j.breast.2016.07.003_bib18","first-page":"154","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"41","author":"Elston","year":"2002","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.breast.2016.07.003_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.2007.13.7083","article-title":"Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer","volume":"27","author":"Generali","year":"2009","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10549-010-1063-0","article-title":"Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients","volume":"123","author":"Mele","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1677\/erc.1.01216","article-title":"Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin\/tamoxifen therapy for breast cancer","volume":"13","author":"Generali","year":"2006","journal-title":"Endocrine Related Cancer"},{"issue":"10","key":"10.1016\/j.breast.2016.07.003_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djp082","article-title":"Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer","volume":"101","author":"Cheang","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2016.07.003_bib23","series-title":"WHO handbook for reporting results of cancer treatment","author":"Organisation WH","year":"1978"},{"issue":"1","key":"10.1016\/j.breast.2016.07.003_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1020274709327","article-title":"Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy","volume":"76","author":"Cure","year":"2002","journal-title":"Breast cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2016.07.003_bib25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1200\/JCO.2002.20.5.1304","article-title":"Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes","volume":"20","author":"Rouzier","year":"2002","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2016.07.003_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1999.17.1.143","article-title":"Physical and psychological morbidity after axillary lymph node dissection for breast cancer","volume":"17","author":"Hack","year":"1999","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"10","key":"10.1016\/j.breast.2016.07.003_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/SLA.0b013e3182654494","article-title":"Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial","volume":"256","author":"Hunt","year":"2012","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.breast.2016.07.003_bib30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2007.15.0326","article-title":"Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference","volume":"26","author":"Buchholz","year":"2008","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2016.07.003_bib31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","article-title":"Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer","volume":"19","author":"Kaufmann","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"43","key":"10.1016\/j.breast.2016.07.003_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/jncimonographs\/lgr037","article-title":"International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fourth symposium on primary systemic therapy in the management of operable breast cancer, Cremona, Italy","volume":"2011","author":"Berruti","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.breast.2016.07.003_bib33","doi-asserted-by":"crossref","first-page":"e105316","DOI":"10.1371\/journal.pone.0105316","article-title":"Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis","volume":"9","author":"Fu","year":"2014","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.breast.2016.07.003_bib34","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J\u00a0Clin Oncol Official J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.breast.2016.07.003_bib35","first-page":"617","article-title":"Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast","volume":"27","author":"Drew","year":"2001","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2016.07.003_bib36","first-page":"237","article-title":"Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia","volume":"54","author":"Aslani","year":"2011","journal-title":"Can J Surg J Can de Chir"},{"key":"10.1016\/j.breast.2016.07.003_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2147\/OTT.S50394","article-title":"Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injection","volume":"7","author":"Tausch","year":"2014","journal-title":"OncoTargets Ther"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4048\/jbc.2014.17.3.244","article-title":"Clinical significance of the axillary arch in sentinel lymph node biopsy","volume":"17","author":"Kil","year":"2014","journal-title":"J\u00a0Breast Cancer"},{"issue":"4","key":"10.1016\/j.breast.2016.07.003_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clbc.2013.12.009","article-title":"Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes","volume":"14","author":"Wei","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"10.1016\/j.breast.2016.07.003_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.breast.2016.07.003_bib41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.breast.2016.07.003_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/000313481408000226","article-title":"Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer","volume":"80","author":"Koslow","year":"2014","journal-title":"Am Surg"},{"issue":"4","key":"10.1016\/j.breast.2016.07.003_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1245\/s10434-013-3350-6","article-title":"Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society","volume":"21","author":"Park","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.breast.2016.07.003_bib44","first-page":"832","article-title":"Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection","volume":"33","author":"Kuijt","year":"2007","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"3","key":"10.1016\/j.breast.2016.07.003_bib45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4048\/jbc.2014.17.3.250","article-title":"Use of fluorescence imaging in combination with patent blue dye versus patent blue dye alone in sentinel lymph node biopsy in breast cancer","volume":"17","author":"Tong","year":"2014","journal-title":"J\u00a0Breast Cancer"},{"issue":"1","key":"10.1016\/j.breast.2016.07.003_bib46","first-page":"46","article-title":"The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer","volume":"41","author":"Rubio","year":"2015","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616301114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616301114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:35:45Z","timestamp":1760776545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616301114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":46,"alternative-id":["S0960977616301114"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.07.003","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}